Author

En Hu

Institutions: Fujian Medical University, Maastricht University Medical Centre, Mengchao Hepatobiliary Hospital, Maastro Clinic, Fuzhou University

Observed institutions: Fujian Medical University, Maastricht University Medical Centre, Mengchao Hepatobiliary Hospital, Maastro Clinic, Fuzhou University

ORCID: 0009-0004-7193-7113

Observed ORCID: 0009-0004-7193-7113

OpenAlex ID: A5125906837

Urinary Proteomics Enables Noninvasive and Longitudinal Monitoring of Tumor Burden Dynamics and Early Recurrence in Hepatocellular Carcinoma

2026 · Xiaohua Xing, En Hu, et al. · Molecular & Cellular Proteomics

Cross-disease multi-omics integration reveals shared mechanisms driving the breast cancer-rheumatoid arthritis association

2026 · En Hu, Peiyu Qiu · Next research.

Integrated Radioproteomic Modeling for Early Recurrence Prediction and Metabolic Characterization in Hepatocellular Carcinoma

2026 · Qiuyu Zhuang, Tongtong Xu, et al. · JCO Precision Oncology

Mass spectrometry-based de novo sequencing reveals non-canonical neoantigens with antitumor efficacy in hepatocellular carcinoma

2026 · Xiaohua Xing, Mingxin Liu, et al. · JHEP Reports

Works count: 4

Citation count:

H-index:

I10-index: